1985
DOI: 10.1016/0014-5793(85)80186-1
|View full text |Cite
|
Sign up to set email alerts
|

tRNA binding to programmed ribosomes increases the ribosomal affinity for tuberactinomycin O

Abstract: The binding of i4C-labelled tuberactinomycin 0 was analysed in equilibrium dialysis cells. The ionic conditions and the concentration of the labelled drug used in the binding assays allowed the binding of just one drug molecule per non-programmed ribosome. Under these conditions, the occupation of the ribosomal P-site by deacylated tRNAP" in the presence. of poly(U) increased the amount of [%]tuberactinomycin 0 bound by a factor of two. Kanamycin, gentamicin and neomycin reduced the binding of tuberactinomycin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1987
1987
2014
2014

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 14 publications
(12 reference statements)
0
1
0
Order By: Relevance
“…Tuberactinomycins (e.g., viomycin and capreomycin) are natural antibiotics that bind the interface of the 30S and 50S subunit of the ribosome and thereby inhibit translocation. These drugs have been used for the treatment of Mycobacterium tuberculosis infections including the multi-drug resistant types [ 152 , 153 , 154 ]. Thermorubins also bind at the interspace spanning the two ribosomal subunits and inhibits the binding of fMet-tRNA to the P-site [ 155 ].…”
Section: Targeting Trnas In the Ribosomementioning
confidence: 99%
“…Tuberactinomycins (e.g., viomycin and capreomycin) are natural antibiotics that bind the interface of the 30S and 50S subunit of the ribosome and thereby inhibit translocation. These drugs have been used for the treatment of Mycobacterium tuberculosis infections including the multi-drug resistant types [ 152 , 153 , 154 ]. Thermorubins also bind at the interspace spanning the two ribosomal subunits and inhibits the binding of fMet-tRNA to the P-site [ 155 ].…”
Section: Targeting Trnas In the Ribosomementioning
confidence: 99%